The high expression levels of tumor-infiltrating lymphocytes (TILs), programmed death ligand protein 1 (PD-L1), coupled with an increased TMB; microsatellite instability (MSI), and mismatch repair deficiency (MMR) in TNBC make it a potential candidate for immunotherapy [73, 74]. Here, CD274 is linked to neoplasm.